144 related articles for article (PubMed ID: 11502741)
1. An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer.
Reiter R; Wellstein A; Riegel AT
J Biol Chem; 2001 Oct; 276(43):39736-41. PubMed ID: 11502741
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
[TBL] [Abstract][Full Text] [Related]
3. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
Reiter R; Oh AS; Wellstein A; Riegel AT
Oncogene; 2004 Jan; 23(2):403-9. PubMed ID: 14691461
[TBL] [Abstract][Full Text] [Related]
4. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA
Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825
[TBL] [Abstract][Full Text] [Related]
5. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.
Kuang SQ; Liao L; Zhang H; Lee AV; O'Malley BW; Xu J
Cancer Res; 2004 Mar; 64(5):1875-85. PubMed ID: 14996752
[TBL] [Abstract][Full Text] [Related]
6. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.
List HJ; Lauritsen KJ; Reiter R; Powers C; Wellstein A; Riegel AT
J Biol Chem; 2001 Jun; 276(26):23763-8. PubMed ID: 11328819
[TBL] [Abstract][Full Text] [Related]
7. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C
Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902
[TBL] [Abstract][Full Text] [Related]
8. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation.
Erenburg I; Schachter B; Mira y Lopez R; Ossowski L
Mol Endocrinol; 1997 Dec; 11(13):2004-15. PubMed ID: 9415404
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
Lahusen T; Fereshteh M; Oh A; Wellstein A; Riegel AT
Cancer Res; 2007 Aug; 67(15):7256-65. PubMed ID: 17671194
[TBL] [Abstract][Full Text] [Related]
10. Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.
Azorsa DO; Cunliffe HE; Meltzer PS
Breast Cancer Res Treat; 2001 Nov; 70(2):89-101. PubMed ID: 11768608
[TBL] [Abstract][Full Text] [Related]
11. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
Oh AS; Lahusen JT; Chien CD; Fereshteh MP; Zhang X; Dakshanamurthy S; Xu J; Kagan BL; Wellstein A; Riegel AT
Mol Cell Biol; 2008 Nov; 28(21):6580-93. PubMed ID: 18765637
[TBL] [Abstract][Full Text] [Related]
13. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.
Anzick SL; Kononen J; Walker RL; Azorsa DO; Tanner MM; Guan XY; Sauter G; Kallioniemi OP; Trent JM; Meltzer PS
Science; 1997 Aug; 277(5328):965-8. PubMed ID: 9252329
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P
Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu.
Bouras T; Southey MC; Venter DJ
Cancer Res; 2001 Feb; 61(3):903-7. PubMed ID: 11221879
[TBL] [Abstract][Full Text] [Related]
16. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
17. AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines.
Wong LJ; Dai P; Lu JF; Lou MA; Clarke R; Nazarov V
BMC Cancer; 2006 May; 6():111. PubMed ID: 16670003
[TBL] [Abstract][Full Text] [Related]
18. AIB1 enhances estrogen-dependent induction of cyclin D1 expression.
Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA
Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796
[TBL] [Abstract][Full Text] [Related]
19. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
[TBL] [Abstract][Full Text] [Related]
20. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.
Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M
Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
